Skip to main content

Advertisement

Articles

Page 2 of 47

  1. Runt-related transcription factor 1 (RUNX1) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters and can accelerate apoptosis in various tumors. However, the r...

    Authors: Mei Hong, Jing He, Duo Li, Yuanyuan Chu, Jiarui Pu, Qiangsong Tong, Harish C. Joshi, Shaotao Tang and Shiwang Li

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:52

    Content type: Research

    Published on:

  2. In-depth analysis of global RNA sequencing has enabled a comprehensive overview of cellular transcriptomes and revealed the pervasive transcription of divergent RNAs from promoter regions across eukaryotic gen...

    Authors: Lidia Chellini, Valentina Frezza and Maria Paola Paronetto

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:51

    Content type: Review

    Published on:

  3. Inhibition of ABC transporters is considered the most effective way to circumvent multidrug resistance (MDR). In the present study, we evaluated the MDR modulatory potential of ERK5-IN-1, a potent extracelluar...

    Authors: Fang Wang, Delan Li, ZongHeng Zheng, Kenneth Kin Wah To, Zhen Chen, Mengjun Zhong, Xiaodong Su, Likun Chen and Liwu Fu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:50

    Content type: Research

    Published on:

  4. CAR T cell-based therapies have shown promising results in hematological malignancies. Results of CAR T cell projects in solid tumors have been less impressive, and factors including lack of targetable antigen...

    Authors: Elham Masoumi, Leila Jafarzadeh, Hamid Reza Mirzaei, Khadijeh Alishah, Keyvan Fallah-Mehrjardi, Hosein Rostamian, Mohammad Khakpoor-Koosheh, Reza Meshkani, Farshid Noorbakhsh and Jamshid Hadjati

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:49

    Content type: Research

    Published on:

  5. Molecular profiling of DNA and RNA has provided valuable new insights into the genetic basis of non-malignant and malignant disorders, as well as an increased understanding of basic mechanisms that regulate hu...

    Authors: Maria Teresa Di Martino, Stefania Meschini, Katia Scotlandi, Chiara Riganti, Enrico De Smaele, Francesca Zazzeroni, Massimo Donadelli, Carlo Leonetti and Michele Caraglia

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:48

    Content type: Meeting Report

    Published on:

  6. The promising expectations about personalized medicine have opened the path to routine large-scale sequencing and increased the importance of genetic counseling for hereditary cancers, among which hereditary b...

    Authors: Giulia Federici and Silvia Soddu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:46

    Content type: Review

    Published on:

  7. In the original publication of this manuscript [1], Fig. 2 contains incorrect labels and feedback loops. The revised version of Fig. 2 is shown below.

    Authors: Xiafeng Peng, Han Gao, Rui Xu, Huiyu Wang, Jie Mei and Chaoying Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:45

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:27

  8. FK506-binding protein 9 (FKBP9) is amplified in high-grade gliomas (HGGs). However, the roles and mechanism(s) of FKBP9 in glioma are unknown.

    Authors: Huizhe Xu, Peng Liu, Yumei Yan, Kun Fang, Dapeng Liang, Xiukun Hou, Xiaohong Zhang, Songyan Wu, Jianmei Ma, Ruoyu Wang, Tao Li, Haozhe Piao and Songshu Meng

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:44

    Content type: Research

    Published on:

  9. In the original publication of this manuscript [1], Fig. 1 contained a typographical error (‘Metabolic’ incorrectly written as ‘Metabolig’).

    Authors: Maria Carla Bosco, Gabriella D’. Orazi and Donatella Del Bufalo

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:43

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:8

  10. We have previously described CLDN6 as a tumor suppressor gene in breast cancer. Here, a new finding is that CLDN6 was upregulated under hypoxia, a commonly recognized factor that promotes tumor metastasis. In ...

    Authors: Yiyang Jia, Yantong Guo, Qiu Jin, Huinan Qu, Da Qi, Peiye Song, Xiaoli Zhang, Xinqi Wang, Wenhong Xu, Yuan Dong, Yingying Liang and Chengshi Quan

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:42

    Content type: Research

    Published on:

  11. The oncogene MYCN is critical for tumorigenesis of several types of cancers including neuroblastoma. We previously reported that miR-506-3p repressed MYCN expression in neuroblastoma cells. However, the mechan...

    Authors: Zhenze Zhao, Spencer D. Shelton, Alejandro Oviedo, Amy L. Baker, Collin P. Bryant, Soroush Omidvarnia and Liqin Du

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:41

    Content type: Research

    Published on:

  12. Osteosarcoma (OS) is an aggressive malignant neoplasm that still suffers from poor prognosis in the case of distal metastases or occurrence of multi-drug resistance. It is therefore crucial to find novel thera...

    Authors: Stefania Lenna, Chiara Bellotti, Serena Duchi, Elisa Martella, Marta Columbaro, Barbara Dozza, Marco Ballestri, Andrea Guerrini, Giovanna Sotgiu, Tommaso Frisoni, Luca Cevolani, Greta Varchi, Mauro Ferrari, Davide Maria Donati and Enrico Lucarelli

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:40

    Content type: Research

    Published on:

  13. New therapies are urgently needed in melanoma particularly in late-stage patients not responsive to immunotherapies and kinase inhibitors.

    Authors: Wei Liu, Paweł Stachura, Haifeng C. Xu, Nikkitha Umesh Ganesh, Fiona Cox, Ruifeng Wang, Karl S. Lang, Jay Gopalakrishnan, Dieter Häussinger, Bernhard Homey, Philipp A. Lang and Aleksandra A. Pandyra

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:38

    Content type: Research

    Published on:

  14. Arnidiol is a pentacyclic triterpene diol that has multiple pharmacological activities. However, the apoptotic activities of arnidiol in human cancer cells have not yet been explored, nor has the mechanism by ...

    Authors: Jinjiao Hu, Hongwei Zhang, Jie Li, Xiuxing Jiang, Yanhao Zhang, Qin Wu, liwen Shen, Jingshan Shi and Ning Gao

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:37

    Content type: Research

    Published on:

  15. Cancer-associated fibroblasts (CAFs) are an important part of the tumour microenvironment, and their functions are of great concern. This series of experiments aimed to explore how Yes-associated protein 1 (YA...

    Authors: Tianyu Shen, Yang Li, Shimiao Zhu, Jianpeng Yu, Boya Zhang, Xuanrong Chen, Zheng Zhang, Yuan Ma, Yuanjie Niu and Zhiqun Shang

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:36

    Content type: Research

    Published on:

  16. The authors have retracted this article [1] because the bands shown in Fig. 5 panel D for GTP-RhoA/Control, GTP-RhoA/Sunitinib (2 and 64 nM) and GTP-RhoA/HM-3 (4.5 and 72 uM) are not data generated as part of ...

    Authors: Jialiang Hu, Wenjing Wang, Chen Liu, Mengwei Li, Edouard Nice and Hanmei Xu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:35

    Content type: Retraction Note

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:381

  17. Odontogenic tumors (OT) are considered rare events and their epidemiologic data are scarce and under-estimated in developing countries because there is no systematic collection of clinical features including h...

    Authors: Marco de Feo, Cristina De Leo, Umberto Romeo, Paola Muti, Giovanni Blandino and Silvia Di Agostino

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:34

    Content type: Commentary

    Published on:

  18. Renal cell carcinoma (RCC) is a highly vascular tumor and patients with low risk metastatic RCC of clear-cell histological sub-type (mccRCC) are treated with tyrosine-kinase inhibitors (TKIs), sunitinib, as th...

    Authors: Ninadh M. D’Costa, Matthew R. Lowerison, Peter A. Raven, Zheng Tan, Morgan E. Roberts, Raunak Shrestha, Matthew W. Urban, Cesar U. Monjaras-Avila, Htoo Zarni Oo, Antonio Hurtado-Coll, Claudia Chavez-Munoz and Alan I. So

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:33

    Content type: Research

    Published on:

  19. Exosomes are essential for tumor growth, metastasis, and are used as novel signaling molecules in targeted therapies. Therefore, exosomal miRNAs can be used in new diagnostic and therapeutic approaches due to ...

    Authors: Shuchun Wei, Lei Peng, Jiajia Yang, Huaiming Sang, Duochen Jin, Xuan Li, Meihong Chen, Weifeng Zhang, Yini Dang and Guoxin Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:32

    Content type: Research

    Published on:

  20. Recurrence and distant metastasis are still the main factors leading to treatment failure for malignant tumors including nasopharyngeal carcinoma (NPC). Therefore, elucidating the molecular mechanisms underlyi...

    Authors: Chaosheng Yu, Fang Chen, Xiaoqi Wang, Zhimou Cai, Mengxue Yang, Qingwen Zhong, Jialian Feng, Junzheng Li, Congxiang Shen and Zhong Wen

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:31

    Content type: Research

    Published on:

  21. BRD7 is a tumor suppressor known to inhibit cell proliferation and cell cycle progression and initiate apoptosis in breast cancer. However, the function and underlying molecular events of BRD7 in tumor invasio...

    Authors: Weihong Niu, Yanwei Luo, Yao Zhou, Mengna Li, Chunchun Wu, Yumei Duan, Heran Wang, Songqing Fan, Zheng Li, Wei Xiong, Xiaoling Li, Guiyuan Li, Caiping Ren, Hui Li and Ming Zhou

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:30

    Content type: Research

    Published on:

  22. Drug resistance is a major obstacle to treating cancers because it desensitizes cancer cells to chemotherapy. Recently, attention has been focused on changes in the tumor immune landscape after the acquisition...

    Authors: Haifang Wang, Chen Fu, Jun Du, Hongsheng Wang, Rui He, Xiaofeng Yin, Haixia Li, Xin Li, Hongxia Wang, Kui Li, Lei Zheng, Zongcai Liu and Yurong Qiu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:29

    Content type: Research

    Published on:

  23. Sirtuin-7 (SIRT7) is associated with the maintenance of tumorigenesis. However, its functional roles and oncogenic mechanisms in prostate cancer (PCa) are poorly understood. Here, we investigated the roles and...

    Authors: Mao Ding, Chen-Yi Jiang, Yu Zhang, Jing Zhao, Bang-Min Han and Shu-Jie Xia

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:28

    Content type: Research

    Published on:

  24. Hypoxia is a classic characteristic of the tumor microenvironment with a significant impact on cancer progression and therapeutic response. Hypoxia-inducible factor-1 alpha (HIF-1α), the most important transcr...

    Authors: Xiafeng Peng, Han Gao, Rui Xu, Huiyu Wang, Jie Mei and Chaoying Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:27

    Content type: Review

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:45

  25. Glioblastoma multiforme is a CNS cancer characterized by diffuse infiltrative growth, aggressive clinical behavior and very poor prognosis. The state-of-art clinical approach to this disease consists of surgic...

    Authors: Claudia Abbruzzese, Silvia Matteoni, Michele Persico, Veronica Villani and Marco G. Paggi

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:26

    Content type: Commentary

    Published on:

  26. Metastasis and recurrence, wherein circulating tumour cells (CTCs) play an important role, are the leading causes of death in colorectal cancer (CRC). Metastasis-initiating CTCs manage to maintain intravascula...

    Authors: Qiong Huang, Shaowei Li, Xingbin Hu, Mengting Sun, Qijing Wu, Huiru Dai, Yujing Tan, Fei Sun, Chunlin Wang, Xiaoxiang Rong, Wangjun Liao, Jianjun Peng, Jianjun Xiao, Li Huang, Jiao Wang, Bishan Liang…

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:25

    Content type: Research

    Published on:

  27. Hepatocellular carcinoma (HCC) is a common primary malignant tumor which usually progresses to an advanced stage because of late diagnosis. Sorafenib (Sora) is a first line medicine for advanced stage HCC; how...

    Authors: Jiao Feng, Weiqi Dai, Yuqing Mao, Liwei Wu, Jingjing Li, Kan Chen, Qiang Yu, Rui Kong, Sainan Li, Jie Zhang, Jie Ji, Jianye Wu, Wenhui Mo, Xuanfu Xu and Chuanyong Guo

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:24

    Content type: Research

    Published on:

  28. Tripartite motif-containing proteins (TRIM) play a crucial role in carcinogenesis. Little attention has been focused on the possible functions of TRIM6 on carcinogenesis.

    Authors: Shuier Zheng, Chenliang Zhou, Yonggang Wang, Hongtao Li, Yong Sun and Zan Shen

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:23

    Content type: Research

    Published on:

  29. The mechanism underlying sorafenib resistance in hepatocellular carcinoma (HCC) remains unclear. Accumulating evidence suggests that tumor-initiating cells (TICs) are a pivotal driving force. Both CD44 and Hed...

    Authors: Siqi Wang, Yang Wang, Xiaodong Xun, Changkun Zhang, Xiao Xiang, Qian Cheng, Shihua Hu, Zhao Li and Jiye Zhu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:22

    Content type: Research

    Published on:

  30. In the original publication of this article [1], the molecular weight of RBMS3 was incorrectly noted as 38 KDa within Fig 1A, Fig 2A and Fig 2B. The figures have been updated to list the correct molecular weig...

    Authors: Lei Zhu, Pei-Wen Xi, Xiao-Xia Li, Xi Sun, Wen-Bin Zhou, Tian-Song Xia, Liang Shi, Yue Hu, Qiang Ding and Ji-Fu Wei

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:21

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:105

  31. Exosomes play crucial roles in regulating the crosstalk between normal and cancer cells in the tumor microenvironment, and in regulating cancer proliferation, migration and invasion through their cargo molecules.

    Authors: Xiu-Yan Huang, Zi-Li Huang, Jin Huang, Bin Xu, Xin-Yu Huang, Yong-Hua Xu, Jian Zhou and Zhao-You Tang

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:20

    Content type: Research

    Published on:

  32. In the original publication of this manuscript [1], Fig. 6 contains a repeated image in error (the left image of ‘Migration’ and the left image of ‘Invasion’).

    Authors: Yi-fang Lu, Jia-rui Yu, Zhao Yang, Guan-xia Zhu, Peng Gao, Huan Wang, Si-yuan Chen, Jie Zhang, Mei-yue Liu, Yi Niu, Xiao-mei Wei, Wei Wang, Feng-jin Ye, Li-xin Zhang, Yue Zhao and Guo-gui Sun

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:19

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:301

  33. Recently, the roles of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in human diseases have been unveiled, this research was conducted to explore the impacts of lncRNA SET-binding factor 2-antisense RN...

    Authors: Wenfei Xia, Yun Liu, Teng Cheng, Tao Xu, Menglu Dong and Xiaopeng Hu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:18

    Content type: Research

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:60

  34. STAT5 plays an important role in the transformation of hematopoietic cells by BCR-ABL. However, the downstream target genes activated by STAT5 in chronic myeloid leukemia (CML) cells remain largely unclear. He...

    Authors: Zi-Yuan Nie, Min Yao, Zhan Yang, Lin Yang, Xiao-Jun Liu, Jing Yu, Ying Ma, Nan Zhang, Xiao-Yan Zhang, Meng-Han Liu, Ling-Ling Jiang and Jian-Min Luo

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:17

    Content type: Research

    Published on:

  35. Our previous study showed Musashi2 (MSI2) promoted chemotherapy resistance and pernicious biology of pancreatic cancer (PC) by down-regulating Numb and p53. We further explored the novel molecular mechanism in...

    Authors: Weiwei Sheng, Xiaoyang Shi, Yiheng Lin, Jingtong Tang, Chao Jia, Rongxian Cao, Jian Sun, Guosen Wang, Lei Zhou and Ming Dong

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:16

    Content type: Research

    Published on:

  36. In the original publication of this manuscript [1], there are three errors in Fig. 1. The identified errors do not affect the conclusions of the work.

    Authors: Yongkui Li, Jie Shi, Shanshan Qi, Jian Zhang, Dong Peng, Zhenzhen Chen, Guobin Wang, Zheng Wang and Lin Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:15

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:196

  37. In the original publication of this manuscript [1], the author mislabeled the CTL group and ZNF326 group in Fig. 2-I,J (MTT result). The revised Fig. 2 is shown below.

    Authors: Xinmiao Yu, Minghao Wang, Jingjing Wu, Qiang Han and Xiupeng Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:14

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:40

  38. Mps1 binding protein (MOB1) is one of the core components of the mammalian Hippo pathway and plays important roles in cancer development. However, its expression, function and regulation in pancreatic ductal a...

    Authors: Ming Quan, Zhiqin Chen, Feng Jiao, Xiuying Xiao, Qing Xia, Jingde Chen, Qian Chao, Yandong Li, Yong Gao, Haiyan Yang, Liwei Wang and Jiujie Cui

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:13

    Content type: Research

    Published on:

  39. Histone lysine demethylase 4B (KDM4B) has been implicated in various pathological processes and human diseases. Glucose metabolism is the main pattern of energy supply in cells and its dysfunction is closely r...

    Authors: Haijie Li, Jingqin Lan, Guihua Wang, Kaixuan Guo, Caishun Han, Xiaolan Li, Junbo Hu, Zhixin Cao and Xuelai Luo

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:12

    Content type: Research

    Published on:

  40. Mounting evidence suggests that complement components promote tumor progression via modulating immune suppression, angiogenesis, or tumor cell proliferation. However, the role of C3a-C3aR signaling in regulati...

    Authors: Chi Shu, Haoran Zha, Haixia Long, Xinxin Wang, Fei Yang, Jianbao Gao, Chunyan Hu, Li Zhou, Bo Guo and Bo Zhu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:11

    Content type: Research

    Published on:

  41. In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with ‘DMT1’ now corrected to read ‘DNMT1’.

    Authors: Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang and Yen-Hua Huang

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:10

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:474

  42. Localized C3 deposition is a well-known factor of inflammation. However, its role in oncoprogression of gastric cancer (GC) remains obscured. This study aims to explore the prognostic value of C3 deposition an...

    Authors: Kaitao Yuan, Jinning Ye, Zhenguo Liu, Yufeng Ren, Weiling He, Jianbo Xu, Yulong He and Yujie Yuan

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:9

    Content type: Research

    Published on:

  43. Circular RNAs (circRNAs) have recently emerged as a new family of noncoding RNAs that are involved in the causation and progression of various cancers. However, the roles of circRNAs in the tumorigenesis of ga...

    Authors: Guangxu Deng, Tingyu Mou, Jiayong He, Da Chen, Daojun Lv, Hao Liu, Jiang Yu, Shuang Wang and Guoxin Li

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:1

    Content type: Research

    Published on:

  44. Low oxygen condition (hypoxia) is considered a hallmark of rapidly growing solid tumors. The presence of hypoxia renders tumor cells resistant to conventional chemo- and radio-therapy, selecting a more maligna...

    Authors: Maria Carla Bosco, Gabriella D’Orazi and Donatella Del Bufalo

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:8

    Content type: Commentary

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:43

  45. Long noncoding RNAs (lncRNAs) are involved in the progression of various cancers and affect the response to radiotherapy. This study focused on clarifying the underlying mechanism by which lncTUG1 affects the ...

    Authors: Pan Wang, Zhuanbo Yang, Ting Ye, Fei Shao, Jiagen Li, Nan Sun and Jie He

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:7

    Content type: Research

    Published on:

  46. Quiescent/slow cycling cells have been identified in several tumors and correlated with therapy resistance. However, the features of chemoresistant populations and the molecular factors linking quiescence to c...

    Authors: Federica Francescangeli, Paola Contavalli, Maria Laura De Angelis, Silvia Careccia, Michele Signore, Tobias Longin Haas, Federico Salaris, Marta Baiocchi, Alessandra Boe, Alessandro Giuliani, Olga Tcheremenskaia, Alfredo Pagliuca, Ombretta Guardiola, Gabriella Minchiotti, Lidia Colace, Antonio Ciardi…

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:2

    Content type: Research

    Published on:

  47. Recent evidence indicates that metformin inhibits mammalian cancer growth and metastasis through the regulation of microRNAs. Metformin regulates miR-381 stability, which plays a vital role in tumor progressio...

    Authors: Dan Jin, Jiwei Guo, Yan Wu, Weiwei Chen, Jing Du, Lijuan Yang, Xiaohong Wang, Kaikai Gong, Juanjuan Dai, Shuang Miao, Xuelin Li and Guoming Su

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:6

    Content type: Research

    Published on:

  48. LncRNA LINC00662 is closely related to the occurrence and development of cancer. This study aims to explore the effect of LINC00662 on colon cancer tumor growth and metastasis and its molecular mechanism.

    Authors: Bo Cheng, Aimei Rong, Quanbo Zhou and Wenlu Li

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:5

    Content type: Research

    Published on:

  49. MiR-199a-3p (miR-199a) can enhance the chemosensitivity of hepatocellular carcinoma (HCC). Because of the easy degradation of miRNA by direct infusion, effective vehicle-mediated delivery of miR-199a may repre...

    Authors: Guohua Lou, Liang Chen, Caixia Xia, Weina Wang, Jinjin Qi, Aichun Li, Liying Zhao, Zhi Chen, Min Zheng and Yanning Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:4

    Content type: Research

    Published on:

  50. Ovarian cancer (OC) is the most lethal gynecological malignancy and the second leading cause of cancer-related death in women. Treatment with PARP inhibitors (PARPi), such as Olaparib, has been recently introd...

    Authors: Enrica Vescarelli, Giulia Gerini, Francesca Megiorni, Eleni Anastasiadou, Paola Pontecorvi, Luciana Solito, Claudia De Vitis, Simona Camero, Claudia Marchetti, Rita Mancini, Pierluigi Benedetti Panici, Carlo Dominici, Ferdinando Romano, Antonio Angeloni, Cinzia Marchese and Simona Ceccarelli

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:3

    Content type: Research

    Published on:

Annual Journal Metrics

Advertisement